Financial News

CAMP HILL, Pa. — Rite Aid's philanthropic arm has donated $15,000 to an organization that works with universities to develop social justice projects.

The Rite Aid Foundation announced the donation of the grant to Impact Alabama, based in Birmingham, Ala., which plans to use the grant to expand FocusFirst, a vision-screening program for children in Head Start classrooms and lower-income daycares across the state. The foundation previously awarded the group $15,000 in 2010.

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago. But IMS Health and other industry experts agree it could still be years before biosimilars are available to pharmacies and patients in this country.

Alabama's Supreme Court ruled in January that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports. According to the New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

MINNEAPOLIS — Target is planning a rollout in Canada that will be bigger than any single year's worth of its store openings in the United States ever, executives of the company said Wednesday morning in a call with Wall Street analysts to discuss the mass merchandise retailer's fourth-quarter and full-year 2012 results.

CHESAPEAKE, Va. — Dollar Tree reported consolidated net sales for the fourth-quarter jumped 15.4% to $2.25 billion compared with $1.95 billion reported for the quarter ended Jan. 28, 2012. Comparable-store sales increased 2.4%, on top of a 7.3% increase for the fourth quarter 2011.

Earnings per diluted share for the fourth quarter were $1.01, an increase of 26.3% compared with the 80 cents earnings per diluted share reported for the fourth quarter 2011.

NEW YORK — According to published reports, Flowers Foods is set to buy Hostess bread brands, including Wonder bread, for $360 million after no other bidder came forward with a competing offer, a source familiar with the sale acknowledged Wednesday.

According to a Reuters report, Hostess, which went bankrupt last year, was scheduled to host an auction on Thursday for the brands — which also include Butternut, Home Pride, Merita and Nature's Pride — but as no other bids were announced, the company will not go through with an auction.

NEW YORK — A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan, but hasn't heard back from it, according to published reports.

The Associated Press reported that Royalty Pharma's $11-per-share offer for Elan represented a 4% premium over its closing price Friday. Royalty buys royalty interests in drug products that are in late-stage development or have already entered the market, but doesn't develop or market drugs of its own, the AP reported.

When Supervalu announced this past summer a review of strategic alternatives, its goals were to improve its business, better position the company for the future and create the best opportunity to deliver shareholder value. This effort has led to the sale of 877 stores to AB Acquistion.

Following the sale, Supervalu will consist of its wholesaler business, which serves 1,950 stores across the country; Save-A-Lot with approximately 1,300 stores across 35 states; and Supervalu's regional retail food banners Cub, Farm Fresh, Shoppers, Shop 'n Save and Hornbacher's.